Skip to main content
. 2018 Sep 7;2018(9):CD005465. doi: 10.1002/14651858.CD005465.pub4

Summary of findings 5. Summary of findings: Additional exercise plus physiotherapy compared with usual physiotherapy in hospitals.

Additional exercise plus physiotherapy compared with usual physiotherapy for falls prevention in hospitals
Population and setting: older (≥ 65 years) patients in hospital settings
Intervention: additional exercise plus physiotherapy
Comparison: usual physiotherapy
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Usual physiotherapy Additional Exercise
Rate of falls
Length of follow‐up: inpatient stay (mean 29 days) or 2 weeks
Low‐risk population1 RaR 0.59 (0.26 to 1.34) 215
(2 studies)
+ooo
VERY LOW7
One study compared additional exercises versus conventional physiotherapy alone, and 1 study tested additional group standing balance circuit classes
1300 per 1000 py 767 (338 to 1742) per 1000 py
Moderate‐risk population2
3500 per 1000 py 2065 (910 to 4690) per 1000 py
High‐risk population3
6000 per 1000 py 3540 (1560 to 8040) per 1000 py
Risk of falling
Length of follow‐up: inpatient stay (mean 29 days) or 8 weeks
Low‐risk population4 RR 0.36
(0.14 to 0.93)
83
(2 studies)
+ooo
VERY LOW8
One study compared additional exercises versus conventional physiotherapy alone, and 1 study tested additional daily physiotherapy sessions
30 per 1000 11 (4 to 28) per 1000
Moderate‐risk population5
150 per 1000 54 (21 to 140) per 1000
High‐risk population6
340 per 1000 122 (48 to 316) per 1000
Risk of fracture See comment See comment See comment     No data available
Adverse events
Length of follow‐up: 2 weeks
0 events 0 events Not estimable 161
(1 study)
+ooo
VERY LOW9
One study reported no adverse events, two studies did not report this outcome
*Illustrative risks for the control group were derived from all or subgroups of trials in hospitals reporting the outcome. The exact basis for the assumed risk for each outcome is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; py: person years; RaR: Rate Ratio; RR: Risk Ratio;
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Low risk was based on the mean control risk of the 7 (bottom third) trials with the lowest rate of falls. The mean rate of falls = 1.27, rounded to 1.3 per person year; thus 1300 per 1000 person years.

2 Moderate risk was based on the mean control risk of the 7 (middle third) trials with a moderate rate of falls. The mean rate of falls = 3.23, rounded to 3.5 per person year; thus 3500 per 1000 person years.

3 High risk was based on the mean control risk of the 7 (top third) trials with the highest rate of falls. The mean rate of falls = 6.33, rounded to 6.0 per person year; thus 6000 per 1000 person years.

4 Low risk was based on the mean control risk of 10 trials with the lowest risk of falling. The mean risk of falling = 0.034, rounded to 0.03; thus 30 per 1000 people.

5 Moderate risk was based on the mean control risk of 7 (middle third) trials reporting the risk of falling. The mean risk of falling = 0.156, rounded to 0.15; thus 150 per 1000 people.

6 High risk was based on the mean control risk of 6 (top third) trials reporting the risk of falling. The mean risk of falling = 0.340; thus 340 per 1000 people.

7The quality of the evidence was downgraded one level for risk of bias (including unclear risk of selection bias and method of ascertaining falls in one study) and two levels for very serious imprecision (the wide confidence intervals cross the range of estimates of harm and strong effect).

8The quality of the evidence was downgraded one level for risk of bias (including unclear risk of bias in both trials for selection bias and high risk of attrition bias for study contributing 69%), one level for indirectness (possibly limited applicability as both trials conducted in UK rehabilitation settings) and one level for imprecision (total N = 83, wide 95% confidence intervals).

9The quality of the evidence was downgraded one level for indirectness (single trial in Australian rehabilitation setting), two levels for imprecision (no events recorded, inadequate power to assess rare adverse events) and one level for other reasons (concerns that adverse events were not recorded systematically).